Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04190628
Title Safety of ABM-1310 Monotherapy in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors ABM Therapeutics, Inc.
Indications

Advanced Solid Tumor

Therapies

ABM-1310

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST